Back to Search
Start Over
Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopenia
- Source :
- Haematologica
- Publication Year :
- 2019
- Publisher :
- Ferrata Storti Foundation (Haematologica), 2019.
-
Abstract
- Sphingolipids are fundamental to membrane trafficking, apoptosis, and cell differentiation and proliferation. KDSR or 3-keto-dihydrosphingosine reductase is an essential enzyme for de novo sphingolipid synthesis, and pathogenic mutations in KDSR result in the severe skin disorder erythrokeratodermia variabilis et progressiva-4 Four of the eight reported cases also had thrombocytopenia but the underlying mechanism has remained unexplored. Here we expand upon the phenotypic spectrum of KDSR deficiency with studies in two siblings with novel compound heterozygous variants associated with thrombocytopenia, anemia, and minimal skin involvement. We report a novel phenotype of progressive juvenile myelofibrosis in the propositus, with spontaneous recovery of anemia and thrombocytopenia in the first decade of life. Examination of bone marrow biopsies showed megakaryocyte hyperproliferation and dysplasia. Megakaryocytes obtained by culture of CD34+ stem cells confirmed hyperproliferation and showed reduced proplatelet formation. The effect of KDSR insufficiency on the sphingolipid profile was unknown, and was explored in vivo and in vitro by a broad metabolomics screen that indicated activation of an in vivo compensatory pathway that leads to normalization of downstream metabolites such as ceramide. Differentiation of propositus-derived induced pluripotent stem cells to megakaryocytes followed by expression of functional KDSR showed correction of the aberrant cellular and biochemical phenotypes, corroborating the critical role of KDSR in proplatelet formation. Finally, Kdsr depletion in zebrafish recapitulated the thrombocytopenia and showed biochemical changes similar to those observed in the affected siblings. These studies support an important role for sphingolipids as regulators of cytoskeletal organization during megakaryopoiesis and proplatelet formation. ispartof: HAEMATOLOGICA vol:104 issue:5 pages:1036-1045 ispartof: location:Italy status: published
- Subjects :
- Platelets
Blood Platelets
Male
induced pluripotent stem cell
Ceramide
Cellular differentiation
Induced Pluripotent Stem Cells
Biology
Article
megakaryocyte
Platelet Biology & its Disorders
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Erythrokeratodermia variabilis
Megakaryocyte
medicine
Animals
Humans
Metabolomics
Myelofibrosis
Induced pluripotent stem cell
Child
Cells, Cultured
Zebrafish
Sphingolipids
proplatelet
Cell Differentiation
Hematology
medicine.disease
Prognosis
Sphingolipid
Thrombocytopenia
Pedigree
Alcohol Oxidoreductases
medicine.anatomical_structure
chemistry
Mutation
Cancer research
Female
sphingolipid
Stem cell
Megakaryocytes
030215 immunology
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Haematologica
- Accession number :
- edsair.doi.dedup.....27dceab59bf0353e0f8e0609cd148aa2